An official website of the United States government
NIH Guide: Weekly Index for June 23, 2023
Weekly NIH Funding Opportunities and Notices
June 23, 2023
Policy Notices
-
The Use of Generative Artificial Intelligence Technologies is Prohibited for the NIH Peer Review Process
(NOT-OD-23-149)National Institutes of Health
General Notices
-
Notice of Pre-Application Webinar for PAR-23-155: Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
(NOT-CA-23-073)National Cancer Institute
-
Termination of the Requirement for COBRE, INBRE, IDeA-CTR, and NARCH Awards to Provide Supplemental Annual Reports through the Scientific Information Reporting System (SIRS)
(NOT-GM-23-046)National Institute of General Medical Sciences
-
Notice of NHLBI Participation in RFA-NS-22-022 "HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (K99/R00 Independent Clinical Trial Not Allowed)"
(NOT-HL-23-092)National Heart, Lung, and Blood Institute
-
Notice of NHLBI Participation in RFA-NS-22-023 "HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (Independent Basic Experimental Studies with Humans Required)"
(NOT-HL-23-093)National Heart, Lung, and Blood Institute
-
Notice of NHLBI Participation in RFA-NS-22-024 "HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Basic Experimental Studies with Humans Required)"
(NOT-HL-23-094)National Heart, Lung, and Blood Institute
-
Notice of NHLBI Participation in RFA-NS-22-025 "HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)"
(NOT-HL-23-095)National Heart, Lung, and Blood Institute
-
Notice of Pre-Application Technical Assistance Webinar for RFA-MD-23-011, "NIMHD Centers of Excellence in Investigator Development and Community Engagement (P50 - Clinical Trial Optional)
(NOT-MD-23-017)National Institute on Minority Health and Health Disparities
-
Notice of Early Termination of NOT-TR-21-017, Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs
(NOT-TR-23-023)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
-
Notice of Early Termination of NOT-TR-21-022, Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs
(NOT-TR-23-024)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
Notice of Changes to Funding Opportunities
-
Notice of Early Expiration of NOT-AG-23-015, "Notice of Special Interest (NOSI): Alzheimers-Focused Administrative Supplements for NIH Grants that are Not Focused on Alzheimers Disease"
(NOT-AG-23-031)National Institute on Aging
-
Notice of Correction to Agency Routing Identifier for NOT-CA-23-060 "Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology"
(NOT-CA-23-074)National Cancer Institute
-
Notice of NINR Participation in RFA-NS-24-015, HEAL Initiative Partnerships to Advance INterdisciplinary (PAIN) Training in Clinical Pain Research: The HEAL PAIN Cohort Program (T90/R90 Independent Clinical Trial Not Allowed)
(NOT-NR-23-011)National Institute of Nursing Research
-
Notice of Change to Funding Opportunity: RADx-UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional)
(NOT-OD-23-138)National Institute on Drug Abuse
-
Notice of Change to Funding Opportunity: Novel Insights through Cross-Site Analyses of Existing RADx-UP Data (R21 Clinical Trial Not Allowed)
(NOT-OD-23-141)National Institute on Drug Abuse
-
Notice of Change to PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional) in Award Information
(NOT-TR-23-022)National Center for Advancing Translational SciencesNational Center for Advancing Translational Sciences
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for NINDS Clinical Trial Methods in Clinical Neurological Disorders Course (R25 Clinical Trial Not Allowed)
(NOT-NS-23-082)National Institute of Neurological Disorders and Stroke
-
Notice of Intent to Publish a Funding Opportunity Announcement for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
(NOT-NS-23-090)National Institute of Neurological Disorders and StrokeNational Institute of Arthritis and Musculoskeletal and Skin DiseasesEunice Kennedy Shriver National Institute of Child Health and Human Development
Notices of Special Interest
-
Notice of Special Interest (NOSI): Administrative Supplement Program to Help Develop Alzheimers-Focused NIH Grants
(NOT-AG-23-032)National Institute on AgingNational Institute on Alcohol Abuse and AlcoholismNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of General Medical SciencesNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Library of MedicineNational Institute of Mental HealthNational Institute of Nursing ResearchNational Institute of Neurological Disorders and StrokeJohn E. Fogarty International CenterNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringNational Institute on Minority Health and Health DisparitiesDivision of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
-
Notice of Special Interest (NOSI): HIV Cure-Related Research in Diverse Populations
(NOT-AI-23-046)National Institute of Allergy and Infectious DiseasesNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Mental Health
-
Notice of Special Interest (NOSI): Using Targeted Degradation of Protein and non-Protein Targets for the Development of Novel Anti-Infectives
(NOT-AI-23-049)National Institute of Allergy and Infectious Diseases
-
Notice of Special Interest (NOSI): Administrative Supplements for Enhancing Recruitment and Retention of Diverse Populations to Cancer Screening, Cancer Prevention and Symptom Management Clinical Trials
(NOT-CA-23-071)National Cancer Institute
Funding Opportunities
-
Simultaneous and Synergistic Multi-Target Validation for Alzheimers Disease-Related Dementias (R61/R33 Clinical Trial not allowed)
(PAR-23-195)National Institute of Neurological Disorders and StrokeNational Institute on AgingApplication Receipt Date(s): September 15, 2023
-
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional)
(PAR-24-210)National Institute of Mental HealthApplication Receipt Date(s): May 18, 2026
-
CCRP Initiative: Chemical Threat Agent Exposure Resource and Coordination Core (ExRC) (U2C Clinical Trial Not Allowed)
(RFA-ES-23-009)National Institute of Environmental Health SciencesNational Institute of Allergy and Infectious DiseasesNational Eye InstituteNational Institute of Neurological Disorders and StrokeApplication Receipt Date(s): September 28, 2023
-
Limited Competition: High Quality Reference Genomes (UM1 Clinical Trial Not Allowed)
(RFA-HG-23-024)National Human Genome Research InstituteApplication Receipt Date(s): August 15, 2023
-
Limited Competition: Human Pangenome Coordinating Center (U41) Clinical Trial Not Allowed
(RFA-HG-23-025)National Human Genome Research InstituteApplication Receipt Date(s): August 15, 2023
-
Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)
(RFA-HG-23-026)National Human Genome Research InstituteApplication Receipt Date(s): March 3, 2025
-
Center for ELSI Resources and Analysis (U24 Clinical Trial Not Allowed)
(RFA-HG-23-027)National Human Genome Research InstituteOffice of the Director, NIHApplication Receipt Date(s): October 26, 2023
-
The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1 Clinical Trial Optional)
(RFA-HL-24-010)National Heart, Lung, and Blood InstituteNational Cancer InstituteApplication Receipt Date(s): October 2, 2023
-
The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-HL-24-011)National Heart, Lung, and Blood InstituteNational Cancer InstituteApplication Receipt Date(s): October 2, 2023
-
Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
(RFA-OD-23-019)Office of the Director, NIHApplication Receipt Date(s): November 1, 2023
-
Maximizing the Scientific Value of Data Generated by the Environmental influences on Child Health Outcomes (ECHO) Program: Dissertation Grant (R36)
(RFA-OD-23-020)Office of the Director, NIHApplication Receipt Date(s): November 1, 2023
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: November 8, 2024
For technical issues E-mail OER Webmaster